tirzepatide type 1 diabetes as effective at treating early-onset 2 as diabetes diagnosed later in life, research finds FDA Grants Tirzepatide a New

Second Natures peer-reviewed study published in JMIR Formative Research (2025) compared both medications within our programme: 3 Tirzepatide (Mounjaro) cohort (209 people): 22.1% average weight loss at 12 months 95.2% achieved at least 10% weight loss 83.7% achieved at least 15% weight loss Semaglutide (Wegovy) cohort (130 people): 17.1% average weight loss at 12 months 83.1% achieved at least 10% weight loss 56.2% achieved at least 15% weight loss Both cohorts exceeded clinical trial results, suggesting that comprehensive behavioural support enhances outcomes regardless of which medication you use

Many researchers celebrate eating very little without realizing they are losing significant muscle along with fat

Matsui M, Oshima M, Oshima H, Takaku K, Maruyama T, Yodoi J, Taketo MM (1996) Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene

How to use: Apply fresh aloe vera gel to your face

If side effects are persistent or worsen, consulting a healthcare provider is paramount to adjust treatment or explore alternative therapies